Astera Labs (ALAB) General Counsel Sells 10,000 Shares Under 10b5-1
Rhea-AI Filing Summary
Philip Mazzara, General Counsel and Secretary of Astera Labs, Inc. (ALAB), sold 10,000 shares of company common stock on 08/28/2025 under a pre-established Rule 10b5-1 trading plan adopted May 29, 2025. The sales occurred in multiple transactions at prices ranging approximately from $182.55 to $190.91 per share; weighted-average prices are reported for several tranches. Following these dispositions, the reporting person’s beneficial ownership is reported as 161,573 shares, held directly. The Form 4 discloses that the transactions executed automatically under the trading plan.
Positive
- Sales executed under a Rule 10b5-1 trading plan, which indicates pre-established, automated transactions rather than discretionary insider trading
- Reporting person retains significant direct ownership of 161,573 shares after the dispositions
Negative
- Insider sold 10,000 shares in a single reported transaction date, which could be perceived negatively by some investors
- Form 4 lacks aggregate proceeds disclosure (only per-tranche prices and weighted averages are provided)
Insights
TL;DR: Insider sold 10,000 shares via a pre-set 10b5-1 plan, indicating automated, non-discretionary disposal rather than ad hoc selling.
The filing shows a controlled disposition executed under a Rule 10b5-1 plan adopted May 29, 2025. Use of such a plan generally reduces concerns about trading on material nonpublic information because transactions occur pursuant to preset instructions. The remaining direct ownership of 161,573 shares keeps the reporting person materially invested in the company. No derivative holdings or additional disclosures of other relationships are provided in this Form 4.
TL;DR: 10,000 shares sold across multiple tranches at ~$182.55–$190.91, yielding staged disposals under a prearranged plan.
The specifics show multiple weighted-average prices reported and a clear statement that sales were automatic under a 10b5-1 plan. Transaction concentration on a single date (08/28/2025) suggests plan parameters allowed intraday executions. The filing does not disclose proceeds aggregate or motivation beyond the plan, so assessment of financial impact on the individual or signal to investors is limited.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 100 | $182.55 | $18K |
| Sale | Common Stock | 339 | $185.6981 | $63K |
| Sale | Common Stock | 800 | $186.3687 | $149K |
| Sale | Common Stock | 1,716 | $187.5665 | $322K |
| Sale | Common Stock | 2,993 | $188.8774 | $565K |
| Sale | Common Stock | 2,852 | $189.6511 | $541K |
| Sale | Common Stock | 1,200 | $190.4962 | $229K |
Footnotes (1)
- The sales reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 29, 2025. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.9400 to $185.9200, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $186.0500 to $187.0000, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $187.0900 to $188.0700, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $188.1900 to $189.1800, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $189.2000 to $190.0600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $190.2100 to $190.9100, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
